CLINICAL_TRIALS
trial_result
· 2017-12-07
Clinical Trial Update: A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes [Phase 2]
Summary
A Phase 2 study of ASP2151 in subjects with recurrent genital herpes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Herpes Genitalis | Phase 2 | Status: COMPLETED